Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Jul 5;8(1):10197.
doi: 10.1038/s41598-018-28505-8.

Comparison of the expression of cluster of differentiation (CD)39 and CD73 between propofol- and sevoflurane-based anaesthesia during open heart surgery

Affiliations
Randomized Controlled Trial

Comparison of the expression of cluster of differentiation (CD)39 and CD73 between propofol- and sevoflurane-based anaesthesia during open heart surgery

Chung-Sik Oh et al. Sci Rep. .

Abstract

High expression of cluster of differentiation (CD)39 and CD73 has cardio-protective effects. We hypothesised that the expression of CD39 and CD73 would differ between propofol- and volatile anaesthetic-based anaesthesia in patients undergoing open heart surgery (OHS). The objective of this prospective randomized trial was to compare the changes in CD39 and CD73 levels in CD4+ T cells between propofol- and sevoflurane-based anaesthesia during OHS. The study randomly allocated 156 patients undergoing OHS to a propofol or sevoflurane group. Blood was obtained preoperatively and up to 48 hours after weaning from cardiopulmonary bypass (CPB). The expression levels of CD39 and CD73 in circulating CD4+ T cells, serum cytokines and other laboratory parameters were analysed. The primary outcome was the expression of CD39 and CD73 on CD4+ T cells. Demographic data and perioperative haemodynamic changes did not show significant differences between the two groups. The expression of CD39 and CD73 in the sevoflurane group was significantly lower than in the propofol group (P < 0.001). Other laboratory findings including cardiac enzymes and cytokine levels, did not show significant intergroup differences. Propofol attenuated the decrease in CD39 and CD73 in circulating CD4+ T cells compared to sevoflurane-based anaesthesia during OHS.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
CONSORT diagram.
Figure 2
Figure 2
Comparison of changes in CD39 expression in circulating helper T cells between the propofol- and sevoflurane-based anaesthesia groups during open heart surgery (OHS). The expression of CD39 was significantly lower in the sevoflurane group. *An overall significant difference between the propofol and sevoflurane groups. Pairwise comparison (P < 0.05) at each time point with Bonferroni’s correction. Abbreviations: Preop, preoperative time; Weaning, immediate after weaning from cardiopulmonary bypass (CPB); 3 hours, 3 hours after weaning from CPB; 24 hours, 24 hours after weaning from CPB; 48 hours, 48 hours after weaning from CPB.
Figure 3
Figure 3
Comparison of changes in CD73 expression in circulating helper T cells between the propofol- and sevoflurane-based anaesthesia groups during OHS. The expression of CD73 was significantly lower in the sevoflurane group. *An overall significant difference between the propofol and sevoflurane groups. Pairwise comparison (P < 0.05) at each time point with Bonferroni’s correction. Abbreviations: Preop, preoperative time; Weaning, immediate after weaning from CPB; 3 hours, 3 hours after weaning from CPB; 24 hours, 24 hours after weaning from CPB; 48 hours, 48 hours after weaning from CPB.

Similar articles

Cited by

References

    1. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. The Annals of thoracic surgery. 2003;75:S715–S720. doi: 10.1016/S0003-4975(02)04701-X. - DOI - PubMed
    1. De Hert S, Moerman A. Myocardial injury and protection related to cardiopulmonary bypass. Best Pract Res Clin Anaesthesiol. 2015;29:137–149. doi: 10.1016/j.bpa.2015.03.002. - DOI - PubMed
    1. Wan IYP, et al. Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study. The Journal of thoracic and cardiovascular surgery. 2004;127:1624–1631. doi: 10.1016/j.jtcvs.2003.10.043. - DOI - PubMed
    1. Marik PE. Propofol: an immunomodulating agent. Pharmacotherapy. 2005;25:28s–33s. doi: 10.1592/phco.2005.25.5_Part_2.28S. - DOI - PubMed
    1. An, K. et al. Effects of propofol on pulmonary inflammatory response and dysfunction induced by cardiopulmonary bypass. Anaesthesia63, 10.1111/j.1365-2044.2008.05627.x (2008). - PubMed

Publication types

MeSH terms